Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients-Reference-Cited by-同舟云学术

Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients

Published:2013-10-17 Issue:6 Volume:58 Page:1888-1896
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Jeng Wen-Juei¹²,Sheen I-Shyan¹²,Chen Yi-Cheng¹²,Hsu Chao-Wei¹²,Chien Rong-Nan²³,Chu Chia-Ming¹²,Liaw Yun-Fan¹²

Affiliation:

1. Liver Research Unit, Linkou Medical Center; Chang Gung Memorial Hospital; Taipei Taiwan

2. College of Medicine; Chang Gung University; Taipei Taiwan

3. Liver Research Unit; Chang Gung Memorial Hospital; Keelung Taiwan

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26549/fullpdf

Reference23 articles.

1. Chronic hepatitis B: update 2009;Lok;Hepatology,2009

2. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update;Liaw;Hepatol Int,2012

3. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2012

4. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial;Chan;Antivir Ther,2007

5. Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B;Fung;J Viral Hepat,2004

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in the management of hepatitis B virus;Hepatitis B Virus - Pathogenesis and Therapeutic Approaches [Working Title];2024-08-10

2. Long-term hepatitis B surface antigen kinetics after nucleos(t)ide analog discontinuation in patients with noncirrhotic chronic hepatitis B;Liver Research;2024-07

3. PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial;Journal of Hepatology;2024-07

4. A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report;Case Reports in Gastroenterology;2024-04-26

5. Model‐based meta‐analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B‐infected mice;CPT: Pharmacometrics & Systems Pharmacology;2024-03-24